Subjective Experiences of Antipsychotic Treatment: A Comparison of First- and Second-generation Medications among Patients with Schizophrenia
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 7, Issue 1
Abstract
Aims: The patient’s perspective of antipsychotic treatment has been a relatively neglected area of research. Whether subjective experiences of antipsychotic treatment are better among patients on second-generation antipsychotics (SGAs), than those on first-generation antipsychotics (FGAs) has also evoked some controversy. This study attempted a longitudinal comparison of attitudes toward treatment, subjective well-being and quality of life (QOL) between patients on SGAs and FGAs. Socio-demographic and clinical correlates of these subjective experiences were also examined. Methodology: Standardised ratings of insight, psychopathology, side-effects, attitudes, subjective well-being and QOL were carried out among 40 patients with schizophrenia on SGAs and 30 on FGAs, over a 6-month period. Results: Both groups were similar in the first 3-month period, apart from the slightly greater severity of illness in the FGA group. Differences in symptom-severity and side-effects emerged between the groups over the course of follow-up. Moreover, as the study progressed, differences also became apparent in subjective experiences; patients on SGAs had significantly better attitudes, subjective well-being and QOL than those on FGAs. However, differences between individual SGAs (olanzapine and risperidone) on these indices were minimal. The three indices of subjective experience were highly correlated with each other. Older age, being employed, greater insight, lower symptom-severity and the absence of side-effects demonstrated significant positive associations with different aspects of subjective experiences. Conclusions: Patients on SGAs had a more favourable profile of subjective experiences with treatment than those on FGAs. These differences seemed to be determined mainly by differences in symptom-severity and side-effects.
Authors and Affiliations
Subho Chakrabarti, Nisha Warikoo, Sandeep Grover
Keywords
Related Articles
- EP ID EP241847
- DOI 10.9734/INDJ/2016/24769
- Views 135
- Downloads 0
Migralepsy: A Case Report
Background: There are different possible temporal associations between epileptic seizures and headache attacks which have given rise to unclear or controversial terminologies. The classification of the International Leag...
Psychotropic Medication Non-adherence among Psychiatric Patients at King Abdulaziz Hospital-Makkah
Background: Non-adherence to psychotropic medication among psychiatric patients is one among the huge medical problem in Saudi Arabia. Most of the psychiatric patients do not adhere to the instruction of the physician in...
Antihistamine Drug Misuse and Dependency in Headache Patients: A Case Series in a Tertiary Care Headache Center
Aims: To report antihistamine abuse at a tertiary headache center including 6 patients who meet the criteria for substance abuse for intramuscular diphenhydramine (DPH). Presentation of the Cases: Six patients were ident...
Association of Waist Circumference, Body Mass Index and Height with Depressive Symptoms in Adult Women
Aims: Recent evidences suggest that individuals’ body composition can related to depression symptoms. We aimed to examine the relationship between depressive symptoms and waist circumference (WC), body mass index (BMI) a...
A Case-control Study to Identify the Risk Factors of Dementia among Clinically Diagnosed Patients in Kerala
Context: Dementia is one of the most significant challenges of the 21st century because of its health, social and economic impact. In India over 4.1 million people are affected. Dementia still remains a largely hidden pr...